Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
A two pager of what you need to know of Sofosbuvir
New WHO guideline on care and treatment of chronic hepatitis C
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Hepatitis C Treatment Snapshots: Daclatasvir
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
